Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)
7.995
-1.375
(-14.68%)
Streaming Delayed Price
Updated: 12:45 PM EDT, Sep 9, 2026
Add to My Watchlist
Press Releases about Lexaria Bioscience Corp. - Common Stock
Lexaria Receives USD$2.6 Million Tax Rebate Payment
September 01, 2026
Lexaria Enters a Material Transfer Agreement With PegBio
August 13, 2026
Lexaria Announces Effective Date for Reverse Stock Split
July 30, 2026
Lexaria Updates Business Development
July 06, 2026
Lexaria Updates Progress on Human Study #7
May 05, 2026
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
April 07, 2026
Lexaria to Begin New Human Clinical Study in GLP-1
April 01, 2026
Lexaria's Robust Patent Portfolio Continues to Grow
March 26, 2026
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
March 24, 2026
Lexaria Announces New R&D Plans for 2026
March 04, 2026
Lexaria Announces Positive Final Results From Human Pilot Study #5
February 05, 2026
Lexaria Awarded Six Additional Patents
January 22, 2026
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.